Speaker profile
Matthew O'Connor
CEO of Scientific Affairs and Director, Cyclarity Therapeutics
Listed for 4 events in our database
About
Matthew O'Connor is CEO of Scientific Affairs and Director, Cyclarity Therapeutics. Their professional work includes cardiovascular ageing, oxidized cholesterol, drug development.
Speaking appearances
- 2026-12-09
The Longevity Summit 2026
Novato, United States · speaker
- 2026-10-01
ARDD 2026
Boston, United States · speaker
Session: Removing Oxidized Cholesterol: Clinical Trials for a New Approach to Cardiometabolic and Age-Related Disease
- 2026-09-02
2060 Longevity Forum
Aix-en-Provence, France · speaker
Session: Pitch - Cyclarity
Session: From Damage to Repair: Oxidized Cholesterol, Cardiovascular Disease, and Beyond
- 2026-06-29
A4LI H-SPAN Summit D.C.
Washington, D.C., United States · panelist
Panel: Panel - Startups Therapeutically Targeting the Hallmarks of Aging for Meaningful Healthspan Gains
Sources and photo credits
- The Longevity Summit 2026 programme · checked 2026-09-27 ↗
- ARDD 2026 programme · checked 2026-09-27 ↗
- 2060 Longevity Forum programme · checked 2026-09-27 ↗
- A4LI H-SPAN Summit D.C. programme · checked 2026-09-27 ↗
- Professional email ↗
- Profile information ↗
- Profile information ↗
- Photo: Official event speaker gallery ↗